BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35773657)

  • 1. National geographical pattern of COVID-19 hospitalization, case fatalities, and associated factors in patients covered by Iran Health Insurance Organization.
    Damiri S; Shojaee A; Dehghani M; Shahali Z; Abbasi S; Daroudi R
    BMC Public Health; 2022 Jun; 22(1):1274. PubMed ID: 35773657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors.
    Mehrizi R; Golestani A; Malekpour MR; Karami H; Nasehi MM; Effatpanah M; Rezaee M; Shahali Z; Akbari Sari A; Daroudi R
    PLoS One; 2024; 19(2):e0298604. PubMed ID: 38394118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data.
    Mehrizi R; Golestani A; Malekpour MR; Karami H; Nasehi MM; Effatpanah M; Ranjbaran H; Shahali Z; Sari AA; Daroudi R
    Front Public Health; 2023; 11():1280434. PubMed ID: 38164450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case fatality and mortality rates, socio-demographic profile, and clinical features of COVID-19 in the elderly population: A population-based registry study in Iran.
    Esmaeili ED; Fakhari A; Naghili B; Khodamoradi F; Azizi H
    J Med Virol; 2022 May; 94(5):2126-2132. PubMed ID: 35032041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces.
    Hajizadeh N; Baghestani AR; Pourhoseingholi MA; Ashtari S; Fazeli Z; Vahedi M; Zali MR
    World J Hepatol; 2017 May; 9(15):704-710. PubMed ID: 28596818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial and temporal analysis of the COVID-19 incidence pattern in Iran.
    Hazbavi Z; Mostfazadeh R; Alaei N; Azizi E
    Environ Sci Pollut Res Int; 2021 Mar; 28(11):13605-13615. PubMed ID: 33188632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Factors Related to Mortality and Length of Hospitalization among COVID-19 Patients in East Azerbaijan Hospitals, Iran.
    Abdi Tazeh A; Mohammadpoorasl A; Sarbakhsh P; Abbasi M; Dorosti A; Khayatzadeh S; Akbari H
    J Res Health Sci; 2022 Oct; 22(3):e00557. PubMed ID: 36511375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Characteristics and Associated Factors of Mortality in COVID-19 Patients; an Analysis of 16000 Cases in Tehran, Iran.
    Zali A; Gholamzadeh S; Mohammadi G; Azizmohammad Looha M; Akrami F; Zarean E; Vafaee R; Maher A; Khodadoost M
    Arch Acad Emerg Med; 2020; 8(1):e70. PubMed ID: 33134966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficiency Assessment of Dental Units Using Data Envelopment Analysis Approach: The Case of Iran.
    Barouni M; Amiresmaieli MR; Shahravan A; Amini S
    Iran J Public Health; 2017 Apr; 46(4):552-559. PubMed ID: 28540273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring Equity of Geographical Distribution of Specialist Physicians in Iran's Health System.
    Moradi R; Olyaeemanesh A; Mosadeghrad AM; Harirchi I; Larijni B
    Int J Prev Med; 2023; 14():60. PubMed ID: 37351037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can judgments according to case fatality rate be correct all the time during epidemics? Estimated cases based on CFR in different scenarios and some lessons from early case fatality rate of coronavirus disease 2019 in Iran.
    Moradi G; Piroozi B; Mohamadi-Bolbanabad A; Safari H; Shokri A; Rahimi R
    Med J Islam Repub Iran; 2020; 34():26. PubMed ID: 32551315
    [No Abstract]   [Full Text] [Related]  

  • 12. Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran.
    Yousefi M; Fazaeli S; Mohammad-Pour S
    J Public Health (Oxf); 2023 Mar; 45(1):259-266. PubMed ID: 34927698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Perception in the COVID-19 pandemic; a health promotion approach.
    Arefi MF; Babaei AP; Barzanouni S; Ebrahimi S; Salehi AR; Khajehnasiri F; Poursadeghian M
    J Educ Health Promot; 2022; 11():118. PubMed ID: 35677277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survival analysis of socio-demographic and clinical predictors among hospitalized COVID-19 patients in Southern Iran.
    Esfandiari A; Kiani J; Amiri B; Mahmoodi M; Abbasi F; Javanmardi E; Yazdanpanah A; Akhlaghi A; Salari H
    BMC Infect Dis; 2023 Mar; 23(1):175. PubMed ID: 36949422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
    Garg S; Patel K; Pham H; Whitaker M; O'Halloran A; Milucky J; Anglin O; Kirley PD; Reingold A; Kawasaki B; Herlihy R; Yousey-Hindes K; Maslar A; Anderson EJ; Openo KP; Weigel A; Teno K; Ryan PA; Monroe ML; Reeg L; Kim S; Como-Sabetti K; Bye E; Shrum Davis S; Eisenberg N; Muse A; Barney G; Bennett NM; Felsen CB; Billing L; Shiltz J; Sutton M; Abdullah N; Talbot HK; Schaffner W; Hill M; Chatelain R; Wortham J; Taylor C; Hall A; Fry AM; Kim L; Havers FP
    Ann Intern Med; 2021 Oct; 174(10):1409-1419. PubMed ID: 34370517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Disparities of Coronavirus Disease 2019 in Texas, March-July 2020.
    Xavier C; Rasu RS
    South Med J; 2021 Oct; 114(10):649-656. PubMed ID: 34599344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological characteristics and initial spatiotemporal visualisation of COVID-19 in a major city in the Middle East.
    MohammadEbrahimi S; Mohammadi A; Bergquist R; Dolatkhah F; Olia M; Tavakolian A; Pishgar E; Kiani B
    BMC Public Health; 2021 Jul; 21(1):1373. PubMed ID: 34247616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional multicenter linkage study of hospital admissions and mortality due to methanol poisoning in Iranian adults during the COVID-19 pandemic.
    Mahdavi SA; Zamani N; McDonald R; Akhgari M; Kolahi AA; Gheshlaghi F; Ostadi A; Dehghan A; Moshiri M; Rahbar-Taramsari M; Delirrad M; Mohtasham N; Afzali S; Ebrahimi S; Ziaeefar P; Khosravi N; Kazemifar AM; Ghadirzadeh M; Farajidana H; Barghemadi T; Sadeghi F; Hadeiy SK; Hadipourzadeh M; Mesbahi J; Malekpour MR; Arabi M; Jamshidi F; Dadpour B; Hovda KE; Hassanian-Moghaddam H
    Sci Rep; 2022 Jun; 12(1):9741. PubMed ID: 35697919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran.
    Madani S; Shahin S; Yoosefi M; Ahmadi N; Ghasemi E; Koolaji S; Mohammadi E; Mohammadi Fateh S; Hajebi A; Kazemi A; Pakatchian E; Rezaei N; Jamshidi H; Larijani B; Farzadfar F
    BMC Pediatr; 2021 Dec; 21(1):563. PubMed ID: 34893036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical Patterning of Physical Activity Prevalence in Iran: Spatial Analysis of 4 Pooled National Health Surveys Among 119,560 Adults.
    Sahebkar M; Heidarian Miri H; Noormohammadpour P; Tiyuri A; Pakzad R; Mansournia N; Heidari Z; Mansournia MA; Stamatakis E
    J Phys Act Health; 2019 Dec; 16(12):1071-1077. PubMed ID: 31541069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.